The blood-brain barrier is a major hurdle in treating a whole range of diseases affecting the CNS. While it serves a vital role in protecting against...
Estimated as a $3 billion opportunity for Bioasis Technologies, the company's xB3 platform is set to revolutionize the treatment of neurological disease. The technology helps deliver...